Ownership signal CIK-linked ownership evidence from parsed SEC filings. 1 signal
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

0.5%

Beneficial ownership of this reported class.

Event date

31 Jan 2025

Date tied to the ownership event or amendment.

Accepted by SEC

14 Feb 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 1 source field
Symbol
ANAB
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
14 Feb 2025, 11:27:43 UTC
Event date
31 Jan 2025
Prior SEC filing
14 Feb 2025
Source filing
View source filing
Filing notes and source

Key filing fact

Frazier Life Sciences Public Fund, L.P. disclosed 0.5% ownership in AnaptysBio, Inc. Common Stock (ANAB) on 31 Jan 2025.

Key facts

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for AnaptysBio, Inc. Common Stock (ANAB).
  • Disclosed ownership: 0.5%.
  • Date of event: 31 Jan 2025.

Change

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 14 Feb 2025, 11:27.
  • Disclosed stake changed by -1.50 percentage points.
  • Changes between disclosures can reflect transactions, share-count changes or reporting changes; they do not establish a purchase or activist intent.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (25)

Names, ownership percentages, voting power, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power CIK
Frazier Life Sciences Public Fund, L.P. 0.5% 0 148,844
FHMLSP, L.P. 0.5% 148,844 0 148,844
FHMLSP, L.L.C. 0.5% 148,844 0 148,844
Frazier Life Sciences Public Overage Fund, L.P. 0.1% 18,902 0 18,902
FHMLSP Overage, L.P. 0.1% 18,902 0 18,902
FHMLSP Overage, L.L.C. 0.1% 18,902 0 18,902
Frazier Life Sciences X, L.P. 0.1% 18,715 0 18,715
FHMLS X, L.P. 0.1% 18,715 0 18,715
FHMLS X, L.L.C. 0.1% 18,715 0 18,715
Frazier Life Sciences XI, L.P. 0.1% 40,222 0 40,222
FHMLS XI, L.P. 0.1% 40,222 0 40,222
FHMLS XI, L.L.C. 0.1% 40,222 0 40,222
Frazier Healthcare VII, L.P. 0.4% 121,206 0 121,206
Frazier Healthcare VII-A, L.P. 0.1% 34,540 0 34,540
FHM VII, L.P. 0.5% 155,746 0 155,746
FHM VII, L.L.C. 0.5% 155,746 0 155,746
James N. Topper 1.5% 463,241 80,812 382,429
Patrick J. Heron 1.3% 391,539 9,110 382,429
Albert Cha 0.6% 167,746 0 167,746
James Brush 0.6% 167,746 0 167,746
Daniel Estes 0.1% 40,222 0 40,222
Alan Frazier 0.5% 155,746 0 155,746
Nader Naini 0.5% 155,746 0 155,746
Nathan Every 0.5% 160,369 4,623 155,746
Brian Morfitt 0.5% 161,115 5,369 155,746
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .